The FEBS Journal is an international journal devoted to the rapid publication of full-length papers covering a wide range of topics in any area of the molecular life sciences.

Junior-GBM is the Junior Section of the German Society for Biochemistry and Molecular Biology (GBM). It was set up in 2011 to support the career development and networking opportunities of students and young researchers in the molecular life sciences in Germany. The Junior-GBM organise and deliver their own activities, under the supervision of their Society and all members of the Junior-GBM are members of the GBM. Junior-GBM are also part of the FEBS Junior Section. To find out more about the Junior-GBM read their overview post and check out the online talks and other activities they deliver, accesible from the 'Popular contributions' section below.

Ex-academia, now in MedComms. I write a blog called Total Internal Reflection about the human side of science. Postings are generally either opinion/commentary (either serious or silly) or "How To" pieces aimed at improving young scientists' soft skills.  A longer biography and manifesto are on the blog here.

I obtained my PhD in plant molecular biology from the University of Nottingham and have spent the past 30 years in science publishing. I've worked for various journals, including Nature and Trends in Biochemical Sciences, and also edited many books. I was the Executive Editor of FEBS Open Bio from its launch in 2011 until 2019.

biochemistry, molecular biology, bioinformatics, molecular visualisation, technology for teaching and learning

The FEBS-IUBMB-ENABLE Conference is a joint initiative of FEBS, IUBMB, and several leading European biomedical research institutes (the ENABLE partners), building on a successful project originally funded by the EU Horizon 2020 Research and Innovation Programme (2017–2020). These interdisciplinary, international, three-day events are organized by and for young researchers in the molecular life sciences and attract up to 300 participants from around the world. Each conference features a scientific symposium, a career day, and outreach activities. ENABLE (the European Academy for Biomedical Science) was launched in 2017 through the collaboration of four renowned European institutes: the Institute for Research in Biomedicine (IRB Barcelona, Spain), the Novo Nordisk Foundation Center for Protein Research (NNF-CPR, Denmark), the Radboud Institute for Molecular Life Sciences at Radboudumc (Netherlands), and the European School of Molecular Medicine (SEMM, Italy). These core institutions hosted the first four conferences from 2017 to 2021. In 2022, FEBS and IUBMB joined forces with the ENABLE founders to relaunch the initiative as FEBS-IUBMB-ENABLE, expanding its reach and impact. In this new cycle, institutions can apply to become associated centres and host one of the events. 

iam graduated from faculty of science, chemistry and biochemistry dep. i have a biomedical analysis diploma. my master degree focused in treatment diabetes with the combination therapy using natural products and a pharmaceutical. i hope to find a PHD position in biochemistry. mainly my interest in biochemistry. title of thesis( treatment of HFD induced diabetes with combination of metformin and natural products)

Organelle biogenesis, peroxisomes, yeast

I am training to become a physician scientist at Northwestern University. I am completing my PhD thesis work in the lab of Marc Mendillo, PhD. I am passionate about discovering the mechanistic basis of human diseases for the development of novel therapeutic strategies. I previously trained as a research technician under the mentorship of Romel Somwar, PhD in the lab of Marc Ladanyi, MD at Memorial Sloan Kettering Cancer Center. During my undergraduate studies at the University of Notre Dame, I conducted research in the lab of Michael Ferdig, PhD.

Atherosclerosis, inflammatory diseases, biomarkers

I hold a BSc in Biochemistry and an MSc in Medical Biochemistry, followed by a PhD in Medical Biology and Genetics. My research focuses on tumor heterogeneity and drug resistance. I am currently an Assistant Professor at the Faculty of Medicine, Istinye University.